Octave® Bioscience, Inc. Announces Publication of Clinical Validation Study Results of its Novel, Multivariate Multiple Sclerosis Disease Activity (MSDA) Blood Test

MENLO PARK, Calif.–(BUSINESS WIRE)–Octave announces the publication of the clinical validation of the Octave Multiple Sclerosis Disease Activity Test in Clinical Immunology.
Click here to view original post